- Vienna '18
- Athens 2019
- ESCRS Player
- On Demand
- ESCRS iLearn
- ESCRS YO's
First Author: S.Ottosen DENMARK
Co Author(s): T. Ilginis
Back to previous
The purpose of our study is to evaluate the safety and effectiveness of the AcrySof Cachet Phakic Intraocular Lens (pIOL) for correction of moderate to high myopia in Northern Jutland, Denmark.
Ophthalmic Department, Aalborg University Hospital, Denmark.
Our retrospective study was performed to show the preliminary results on patients that have had the AcrySof Cachet pIOL installed in the period from January 2012 until June 2012. This study focuses on visual acuity measured as logarithm of the minimum angle of resolution (logMAR) preoperatively, postoperative uncorrected logMAR, endothelial cell density and any side effects identified in a period of three months postoperative.
10 eyes (5 patients) were implanted with the AcrySof Cachet pIOL. The patients had a mean age of 39 years and 60 % of them were women. Refractive error before pIOL implantation was 8,3 D (±2,6) spherical with no significant cylinder (<0,5 D). Preoperative LogMAR was 0,006 (±0,077) and endothelial cell density was 2750 (±270) cells/mm2. 3 months post operative uncorrected LogMAR was -0,018 (±0,083) and the endothelial cell density was 2745 (ḟ210) cells/mm2. There were no statistically significant differences in pre- and postoperative endothelial cell density (p=0,937) nor visual acuity (p=0,197). There were two incidents of raised intraocular pressure 6 hours postoperative that was normalized the next day with the use of one drop of alfa2 agonist.
This is the first study in Denmark to show that the AcrySof Cachet pIOL provide a favorable refractive correction and an excellent uncorrected visual acuity. No serious short term side effects were observed. Implantation with the AcrySof Cachet pIOL is a good alternative to laser assisted in situ keratomileusis in high myopia.